ArticleCancers2025

Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies.

Maja Bürdek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.